TABLE 2.
Comparative yields of clinically important microorganisms in BM and BD blood culture bottles containing samples from patients receiving antimicrobial therapy
Microorganism(s) | No. of isolates detected in:
|
P value | ||
---|---|---|---|---|
Both bottles | BM bottles only | BD bottles only | ||
Gram-positive cocci | ||||
Staphylococcus aureus | 22 | 10 | 7 | NSa |
Coagulase-negative staphylococci | 11 | 4 | 2 | NS |
Streptococcus viridans group | 5 | 0 | 0 | NS |
Enterococcus spp.b | 22 | 6 | 3 | NS |
Gram-negative bacilli | ||||
Enterobacteriaceaec | 19 | 4 | 2 | NS |
Other gram-negative bacillid | 2 | 3 | 2 | NS |
Anaerobic bacteriae | 0 | 0 | 1 | NS |
Yeastsf | 9 | 12 | 2 | <0.025 |
All microorganisms | 90 | 39 | 19 | <0.01 |
NS, not significant (P > 0.05).
Includes 16 Enterococcus faecalis, 13 Enterococcus faecium, and 2 Enterococcus avium isolates.
Includes 15 Klebsiella pneumoniae, 3 Escherichia coli, 2 Proteus vulgaris, and 2 Serratia marcescens isolates and 1 isolate each of Enterobacter aerogenes, Proteus mirabilis, and Proteus rettgeri.
Includes three Burkholderia cepacia and two Acinetobacter baumannii isolates and one isolate each of Pseudomonas aeruginosa and Stenotrophomonas maltophilia.
Includes one Bacteroides thetaiotaomicron isolate.
Includes 14 Candida albicans, 5 Candida tropicalis, 2 Candida glabrata, and 2 Cryptococcus neoformans isolates.